FERRI, Clodoveo
 Distribuzione geografica
Continente #
NA - Nord America 54.630
EU - Europa 27.413
AS - Asia 22.083
SA - Sud America 2.689
AF - Africa 434
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 40
Totale 107.336
Nazione #
US - Stati Uniti d'America 53.958
GB - Regno Unito 9.997
IT - Italia 7.168
SG - Singapore 6.701
CN - Cina 6.292
HK - Hong Kong 3.010
BR - Brasile 2.070
SE - Svezia 1.969
VN - Vietnam 1.764
DE - Germania 1.623
FI - Finlandia 1.492
UA - Ucraina 1.436
TR - Turchia 1.417
FR - Francia 1.264
RU - Federazione Russa 852
KR - Corea 639
IN - India 557
BG - Bulgaria 504
CA - Canada 289
ID - Indonesia 281
NL - Olanda 243
MX - Messico 226
JP - Giappone 222
AR - Argentina 216
IE - Irlanda 203
BD - Bangladesh 202
ZA - Sudafrica 157
IQ - Iraq 137
AE - Emirati Arabi Uniti 117
PL - Polonia 116
EC - Ecuador 107
PK - Pakistan 106
MY - Malesia 85
ES - Italia 82
CO - Colombia 75
CL - Cile 71
BE - Belgio 68
IR - Iran 67
BZ - Belize 66
SA - Arabia Saudita 61
MA - Marocco 57
RO - Romania 57
PH - Filippine 56
UZ - Uzbekistan 53
EG - Egitto 51
AT - Austria 50
VE - Venezuela 49
LT - Lituania 43
TH - Thailandia 38
TN - Tunisia 38
AU - Australia 37
NP - Nepal 37
CH - Svizzera 36
TW - Taiwan 36
JO - Giordania 35
EU - Europa 34
PY - Paraguay 33
PE - Perù 28
AZ - Azerbaigian 27
IL - Israele 25
KE - Kenya 25
PT - Portogallo 25
CZ - Repubblica Ceca 24
OM - Oman 21
BO - Bolivia 19
UY - Uruguay 19
DZ - Algeria 17
HU - Ungheria 17
BY - Bielorussia 15
DO - Repubblica Dominicana 15
GR - Grecia 15
KG - Kirghizistan 15
AL - Albania 14
KZ - Kazakistan 14
ET - Etiopia 13
LV - Lettonia 13
PA - Panama 13
PS - Palestinian Territory 13
DK - Danimarca 12
JM - Giamaica 12
NO - Norvegia 12
TT - Trinidad e Tobago 12
SN - Senegal 11
CR - Costa Rica 10
CI - Costa d'Avorio 9
LU - Lussemburgo 9
RS - Serbia 9
SY - Repubblica araba siriana 9
CY - Cipro 8
HN - Honduras 8
MD - Moldavia 8
ML - Mali 7
NG - Nigeria 7
SK - Slovacchia (Repubblica Slovacca) 7
GE - Georgia 6
LB - Libano 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
Totale 107.221
Città #
Southend 7.726
Fairfield 5.009
Singapore 4.426
Ashburn 4.112
Santa Clara 4.103
Woodbridge 3.480
Hong Kong 2.971
Jacksonville 2.762
Houston 2.680
Chandler 2.065
Hefei 1.956
Ann Arbor 1.930
Seattle 1.796
Wilmington 1.788
Chicago 1.759
Dearborn 1.675
Cambridge 1.605
San Jose 1.447
Los Angeles 1.399
London 1.162
Beijing 1.116
Nyköping 1.083
Helsinki 1.033
The Dalles 853
Izmir 824
Salt Lake City 772
Modena 624
Milan 612
Seoul 580
Council Bluffs 564
Ho Chi Minh City 548
San Diego 528
Princeton 523
New York 504
Sofia 491
Eugene 448
Rome 447
Hanoi 441
Lauterbourg 399
Tampa 376
Elk Grove Village 336
Dallas 301
Buffalo 286
Des Moines 260
Columbus 253
Moscow 250
Shanghai 221
Atlanta 211
Jakarta 202
São Paulo 194
Redwood City 180
Frankfurt am Main 178
Dublin 174
Bremen 170
Sterling 168
Lancaster 149
Tokyo 137
Bologna 135
Guangzhou 129
Florence 112
Boardman 110
Naples 110
Norwalk 110
Orem 109
Miami 105
Phoenix 105
Dulles 103
Detroit 97
Palermo 97
Falls Church 94
Delhi 92
Istanbul 87
Mexico City 86
Turin 85
Toronto 82
New Delhi 80
Da Nang 79
Warsaw 78
Denver 75
Haiphong 75
Bari 74
Genoa 72
Munich 72
Nanjing 71
Catania 70
Montreal 70
Kansas City 69
Johannesburg 68
Verona 68
Belize City 66
Brooklyn 66
Chennai 64
Belo Horizonte 56
Dong Ket 56
Jinan 56
Manchester 55
San Francisco 54
Kunming 53
Pittsburgh 52
Padova 51
Totale 75.785
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.823
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 938
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 777
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 760
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 624
Semeiotica dell'articolazione temporo-mandibolare 545
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 468
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 445
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
B-cells and mixed cryoglobulinemia 435
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 429
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 428
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 419
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 408
Thymus alterations and systemic sclerosis 383
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 383
Endocrine manifestations of hepatitis C virus infection. 380
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 374
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 371
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 371
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 370
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 369
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 359
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 357
Heart involvement and systemic sclerosis 357
Validation of the classification criteria for cryoglobulinaemic vasculitis 353
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 353
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 348
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 348
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 345
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 345
Cardiac Involvement in Systemic Vasculitis 345
Current treatment of hepatitis C-associated rheumatic diseases. 343
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 343
Scleroderma digital ulcers complicated by infection with fecal pathogens. 341
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 338
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 338
Aortic pulse wave velocity measurement in systemic sclerosis patients. 338
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 336
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 335
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 333
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 331
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 331
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 330
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 327
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 326
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 324
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 324
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 323
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 322
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 321
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 321
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 321
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 320
Elevated Troponin Serum Levels in Adult Onset Still's Disease 319
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 319
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 318
L-Arginine in pregnant scleroderma patients 318
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 316
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 316
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 314
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 313
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 313
Non HCV-related mixed cryoglobulinemia 309
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 308
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 306
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 305
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 304
Platelet gel in the treatment of severe scleroderma skin ulcers. 304
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 303
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 303
The A, B, Cs of viral hepatitis in the biologic era. 302
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 301
Cytokines and HCV-related disorders 300
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 300
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 299
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 298
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 298
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 298
HCV and cryoglobulinemic vasculitis. 296
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 295
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 294
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 293
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 292
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 291
Associations between Systemic Sclerosis and Thyroid Diseases 291
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 289
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 289
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 288
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis 288
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 286
Role of the HLA class II: HCV-related disorders 286
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 284
Cardiovascular risk and prostanoids in systemic sclerosis 283
GISEA: an Italian biological agents registry in rheumatology 283
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. 281
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 280
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 280
Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. 279
Totale 38.443
Categoria #
all - tutte 420.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 420.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.182 0 0 0 0 0 0 0 0 0 0 658 524
2021/20227.902 212 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/202516.486 663 224 296 1.315 3.092 2.336 829 931 1.887 1.376 1.659 1.878
2025/202631.283 1.667 1.205 2.541 4.677 7.266 2.616 3.613 1.479 2.666 2.719 834 0
Totale 108.084